AVIOQ ® HTLV-I/II Microelisa System For the qualitative detection of antibodies to Human T-Lymphotropic Virus Type I (HTLV-I) and/or Human T-Lymphotropic Virus Type II (HTLV-II) in human serum or plasma. It is intended as a screen for donated organs and blood to prevent transmission of HTLV-I and HTLV-II to recipients of cellular blood components and as an aid in clinical diagnosis of HTLV-I or HTLV-II infection and related diseases. 100% sensitivity and 99.95% specificity* The performance characteristics of the Avioq HTLV-I/II Microelisa System combined with the simplicity and efficiency of the test format are an unbeatable combination. The 8-well strip format and only 20µl serum or plasma sample input make this test ideal for automation. *See package insert for 95% Confidence Intervals

HTLV-I viral lysate + anti-human Color HTLV-II viral lysate + enzyme conjugate Recombinant HTLV-I (HRP) coated well p21E Avioq HTLV-I/II Microelisa System is an enzyme-linked immunosorbent assay (ELISA) in which the solid phase (microwells) are coated with purified HTLV-I and HTLV-II viral lysate, and a HTLV-I recombinant p21 E antigen. Upon addition of a diluted test specimen containing antibodies to either HTLV-I or HTLV-II, complexes are formed by the interaction of the antibodies in the sample and the solid phase antigens. Following incubation and a wash to remove unbound material,...